Inhibitory Ly49 receptors on mouse natural killer cells

Current Topics in Microbiology and Immunology

Volumn 350, Issue , 2010, Pages 67-87

  Orr, Mark T ^a   Lanier, Lewis L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A; PROTEIN TYROSINE PHOSPHATASE SHP 2; IMMUNOGLOBULIN RECEPTOR; LIGAND;

ADOPTIVE TRANSFER; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW TRANSPLANTATION; CD8+ T LYMPHOCYTE; CELL SURFACE; CHROMOSOME 6; CONFORMATIONAL TRANSITION; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; DISEASE FREE SURVIVAL; DRUG MEGADOSE; GENE; GENE CONVERSION; GENE DUPLICATION; GENE LOCUS; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HAPLOTYPE; HEMATOLOGIC MALIGNANCY; KLRA GENE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOLID TUMOR; VIRUS INFECTION; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW; C57BL MOUSE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; NEOPLASM; NONOBESE DIABETIC MOUSE; REVIEW;

MURINAE;

ANIMALS; BONE MARROW; BONE MARROW TRANSPLANTATION; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; KILLER CELLS, NATURAL; LIGANDS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; NEOPLASMS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; VIRUS DISEASES;

EID: 78649940624     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-85     Document Type: Article

References (138)

1. Abi-Rached L, Parham P (2005) Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med 201:1319-1332 (Pubitemid 40629074)
2. Adams EJ, Juo ZS, Venook RT et al (2007) Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors. Proc Natl Acad Sci U S A 104:10128-10133 (Pubitemid 47175274)
3. Arase H, Mocarski ES, Campbell AE et al (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296:1323-1326 (Pubitemid 34522789)
4. Asai O, Longo DL, Tian ZG et al (1998) Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest 101:1835-1842 (Pubitemid 28226101)
5. Back J, Malchiodi EL, Cho S et al (2009) Distinct conformations of Ly49 natural killer cell receptors mediate MHC class I recognition in trans and cis. Immunity 31:598-608
6. Barber MA, Zhang T, Gagne BA et al (2008) Ly49G2 receptor blockade reduces tumor burden in a leukemia model but not in a solid tumor model. Cancer Immunol Immunother 57:655-662 (Pubitemid 351641027)
7. Belanger S, Tai LH, Anderson SK et al (2008) Ly49 cluster sequence analysis in a mouse model of diabetes: An expanded repertoire of activating receptors in the NOD genome. Genes Immun 9:509-521
8. Binstadt BA, Brumbaugh KM, Dick CJ et al (1996) Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 5:629-638 (Pubitemid 27062071)
9. Binstadt BA, Billadeau DD, Jevremovic D et al (1998) SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors. J Biol Chem 273:27518-27523 (Pubitemid 28500472)
10. Bix M, Liao NS, Zijlstra M et al (1991) Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 349:329-331 (Pubitemid 21912075)
11. Brennan J, Mahon G, Mager DL et al (1996) Recognition of class I major histocompatibility complex molecules by Ly-49: Specificities and domain interactions. J Exp Med 183:1553-1559
12. Brodin P, Karre K, Hoglund P (2009a) NK cell education: Not an on-off switch but a tunable rheostat. Trends Immunol 30:143-149
13. Brodin P, Lakshmikanth T, Johansson S et al (2009b) The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 113:2434-2441
14. Brown MG, Fulmek S, Matsumoto K et al (1997) A 2-Mb YAC contig and physical map of the natural killer gene complex on mouse chromosome 6. Genomics 42:16-25 (Pubitemid 27215121)
15. Bukowski JF, Woda BA, Habu S et al (1983) Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol 131:1531-1538 (Pubitemid 13048919)
16. Burshtyn DN, Scharenberg AM, Wagtmann N et al (1996) Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4:77-85 (Pubitemid 26056459)
17. Cao D, Hu L, Wang Y et al (2009) Suppression of graft-versus-host disease after adoptive infusion of alloreactive NK cells induced by silencing Ly49C gene in mice. Transpl Immunol 20:243-248
18. Carlyle JR, Mesci A, Fine JH et al (2008) Evolution of the Ly49 and Nkrp1 recognition systems. Semin Immunol 20:321-330
19. Chalifour A, Scarpellino L, Back J et al (2009) A role for cis interaction between the inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 30:337-347
20. Correa I, Raulet DH (1995) Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 2:61-71
21. Daniels BF, Karlhofer FM, Seaman WE et al (1994) A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J Exp Med 180:687-692 (Pubitemid 24224146)
22. Daniels KA, Devora G, Lai WC et al (2001) Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med 194: 29-44 (Pubitemid 32660435)
23. Daws MR, Eriksson M, Oberg L et al (1999) H-2Dd engagement of Ly49A leads directly to Ly49A phosphorylation and recruitment of SHP1. Immunology 97:656-664 (Pubitemid 29356416)
24. Depatie C, Lee SH, Stafford A et al (2000) Sequence-ready BAC contig, physical, and transcriptional map of a 2-Mb region overlapping the mouse chromosome 6 host-resistance locus Cmv1. Genomics 66:161-174 (Pubitemid 30429751)
25. Desrosiers MP, Kielczewska A, Loredo-Osti JC et al (2005) Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat Genet 37:593-599 (Pubitemid 40774887)
26. Dokun AO, Kim S, Smith HR et al (2001) Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2:951-956 (Pubitemid 32976168)
27. Doom CM, Hill AB (2008) MHC class I immune evasion in MCMV infection. Med Microbiol Immunol 197:191-204
28. Dorfman JR, Raulet DH (1998) Acquisition of Ly49 receptor expression by developing natural killer cells. J Exp Med 187:609-618 (Pubitemid 28093363)
29. Doucey MA, Scarpellino L, Zimmer J et al (2004) Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat Immunol 5:328-336 (Pubitemid 38332130)
30. Eriksson M, Ryan JC, Nakamura MC et al (1999a) Ly49A inhibitory receptors redistribute on natural killer cells during target cell interaction. Immunology 97:341-347 (Pubitemid 29274169)
31. Eriksson M, Leitz G, Fallman E et al (1999b) Inhibitory receptors alter natural killer cell interactions with target cells yet allow simultaneous killing of susceptible targets. J Exp Med 190:1005-1012 (Pubitemid 29480829)
32. Fassett MS, Davis DM, Valter MM et al (2001) Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering. Proc Natl Acad Sci U S A 98:14547-14552 (Pubitemid 33121429)
33. Fernandez NC, Treiner E, Vance RE et al (2005) A subset of natural killer cells achieves selftolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105:4416-4423 (Pubitemid 40720789)
34. Franksson L, Sundback J, Achour A et al (1999) Peptide dependency and selectivity of the NK cell inhibitory receptor Ly-49C. Eur J Immunol 29:2748-2758 (Pubitemid 30098999)
35. Fraser KP, Gays F, Robinson JH et al (2002) NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a timedependent and stochastic manner independently of CD94 and NKG2. Eur J Immunol 32:868-878 (Pubitemid 34257564)
36. Fry AM, Lanier LL, Weiss A (1996) Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J Exp Med 184:295-300 (Pubitemid 26247241)
37. Gagnier L, Wilhelm BT, Mager DL (2003) Ly49 genes in non-rodent mammals. Immunogenetics 55:109-115 (Pubitemid 36702748)
38. Galandrini R, Tassi I, Morrone S et al (2001) The adaptor protein shc is involved in the negative regulation of NK cell-mediated cytotoxicity. Eur J Immunol 31:2016-2025 (Pubitemid 32640717)
39. Gasser S, Raulet DH (2006) Activation and self-tolerance of natural killer cells. Immunol Rev 214:130-142 (Pubitemid 44707907)
40. Gays F, Aust JG, Reid DM et al (2006) Ly49B is expressed on multiple subpopulations of myeloid cells. J Immunol 177:5840-5851 (Pubitemid 44628797)
41. George TC, Mason LH, Ortaldo JR et al (1999a) Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J Immunol 162:2035-2043 (Pubitemid 29288822)
42. George TC, Ortaldo JR, Lemieux S et al (1999b) Tolerance and alloreactivity of the Ly49D subset of murine NK cells. J Immunol 163:1859-1867 (Pubitemid 29382186)
43. Glass B, Uharek L, ZeisMet al (1996) Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells. Br J Haematol 93:412-420 (Pubitemid 26150031)
44. Grundemann C, Bauer M, Schweier O et al (2006) Cutting edge: Identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1. J Immunol 176:1311-1315 (Pubitemid 43134270)
45. Gupta N, Scharenberg AM, Burshtyn DN et al (1997) Negative signaling pathways of the killer cell inhibitory receptor and Fc gamma RIIb1 require distinct phosphatases. J Exp Med 186:473-478 (Pubitemid 27332907)
46. Hanke T, Raulet DH (2001) Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors. J Immunol 166:3002-3007 (Pubitemid 33117295)
47. Hanke T, Takizawa H, McMahon CW et al (1999) Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11:67-77 (Pubitemid 29359958)
48. Hao L, NeiM(2004) Genomic organization and evolutionary analysis of Ly49 genes encoding the rodent natural killer cell receptors: Rapid evolution by repeated gene duplication. Immunogenetics 56:343-354 (Pubitemid 39222766)
49. Held W, Kunz B (1998) An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire. Eur J Immunol 28:2407-2416 (Pubitemid 28362715)
50. Held W, Raulet DH (1997) Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic. Eur J Immunol 27:2876-2884 (Pubitemid 27478357)
51. Held W, Roland J, Raulet DH (1995) Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells. Nature 376:355-358
52. Hengel H, Reusch U, Gutermann A et al (1999) Cytomegaloviral control of MHC class I function in the mouse. Immunol Rev 168:167-176 (Pubitemid 29276681)
53. Hof P, Pluskey S, Dhe-Paganon S et al (1998) Crystal structure of the tyrosine phosphatase SHP-2. Cell 92:441-450 (Pubitemid 28101108)
54. Hoglund P, Ohlen C, Carbone E et al (1991) Recognition of beta 2-microglobulin-negative (beta 2 m-) T-cell blasts by natural killer cells from normal but not from beta 2 m- mice: Nonresponsiveness controlled by beta 2 m- bone marrow in chimeric mice. Proc Natl Acad Sci U S A 88:10332-10336 (Pubitemid 21915829)
55. Hoglund P, Glas R, Menard C et al (1998) Beta2-microglobulin-deficient NK cells show increased sensitivity to MHC class I-mediated inhibition, but self tolerance does not depend upon target cell expression of H-2Kb and Db heavy chains. Eur J Immunol 28:370-378 (Pubitemid 28048307)
56. Ito M, Maruyama T, Saito N et al (2006) Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J Exp Med 203:289-295 (Pubitemid 43290837)
57. Johansson MH, Bieberich C, Jay G et al (1997) Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene. J Exp Med 186:353-364 (Pubitemid 27332893)
58. Johansson MH, Hoglund E, Nakamura MC et al (1998) Alpha1/alpha2 domains of H-2D(d), but not H-2L(d), induce "missing self" reactivity in vivo-no effect of H-2L(d) on protection against NK cells expressing the inhibitory receptor Ly49G2. Eur J Immunol 28:4198-4206 (Pubitemid 28558650)
59. Joncker NT, Fernandez NC, Treiner E et al (2009) NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: The rheostat model. J Immunol 182:4572-4580
60. Jonsson AH, Yang L, Kim S et al (2010) Effects of MHC class I alleles on licensing of Ly49A + NK cells. J Immunol 184(7):3424-3432
61. Kane KP (1994) Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J Exp Med 179:1011-1015 (Pubitemid 24065660)
62. Karlhofer FM, Ribaudo RK, YokoyamaWM(1992) MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358:66-70
63. Karre K, Ljunggren HG, Piontek G et al (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675-678 (Pubitemid 16119452)
64. Kielczewska A, Pyzik M, Sun T et al (2009) Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med 206:515-523
65. Kim S, Poursine-Laurent J, Truscott SM et al (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436:709-713 (Pubitemid 41117274)
66. Koh CY, Blazar BR, George T et al (2001) Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. Blood 97:3132-3137
67. Koh CY, Raziuddin A, Welniak LA et al (2002) NK inhibitory-receptor blockade for purging of leukemia: Effects on hematopoietic reconstitution. Biol Blood Marrow Transplant 8:17-25 (Pubitemid 34141547)
68. Koh CY, Ortaldo JR, Blazar BR et al (2003) NK-cell purging of leukemia: Superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade. Blood 102:4067-4075 (Pubitemid 37486990)
69. Kubota A, Kubota S, Lohwasser S et al (1999) Diversity of NK cell receptor repertoire in adult and neonatal mice. J Immunol 163:212-216 (Pubitemid 29295843)
70. Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23:225-274 (Pubitemid 40563170)
71. Lanier LL (2008) Up on the tightrope: Natural killer cell activation and inhibition. Nat Immunol 9:495-502 (Pubitemid 351560518)
72. Lian RH, Li Y, Kubota S et al (1999) Recognition of class I MHC by NK receptor Ly-49C: Identification of critical residues. J Immunol 162:7271-7276 (Pubitemid 29277700)
73. Liao NS, Bix M, Zijlstra M et al (1991) MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity. Science 253:199-202 (Pubitemid 21917142)
74. Ljunggren HG, Van Kaer L, Ploegh HL et al (1994) Altered natural killer cell repertoire in Tap-1 mutant mice. Proc Natl Acad Sci U S A 91:6520-6524 (Pubitemid 24200693)
75. Long EO (2008) Negative signaling by inhibitory receptors: The NK cell paradigm. Immunol Rev 224:70-84
76. Lundqvist A, McCoy JP, Samsel L et al (2007) Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors. Blood 109:3603-3606 (Pubitemid 46572556)
77. MacFarlane AW, Campbell KS (2006) Signal transduction in natural killer cells. Curr Top Microbiol Immunol 298:23-57
78. Makrigiannis AP, Gosselin P, Mason LH et al (1999) Cloning and characterization of a novel activating Ly49 closely related to Ly49A. J Immunol 163:4931-4938 (Pubitemid 29501259)
79. Makrigiannis AP, Pau AT, Saleh A et al (2001) Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J Immunol 166:5034-5043 (Pubitemid 32280716)
80. Makrigiannis AP, Pau AT, Schwartzberg PL et al (2002) A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice. Genomics 79:437-444 (Pubitemid 34211952)
81. Marincola FM, Shamamian P, Alexander RB et al (1994) Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J Immunol 153:1225-1237 (Pubitemid 24228514)
82. Mason LH, Ortaldo JR, Young HA et al (1995) Cloning and functional characteristics of murine large granular lymphocyte-1: A member of the Ly-49 gene family (Ly-49G2). J Exp Med 182:293-303
83. Mason LH, Gosselin P, Anderson SK et al (1997) Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase. J Immunol 159:4187-4196 (Pubitemid 127470573)
84. McQueen KL, Freeman JD, Takei F et al (1998) Localization of five new Ly49 genes, including three closely related to Ly49c. Immunogenetics 48:174-183 (Pubitemid 28352183)
85. McQueen KL, Lohwasser S, Takei F et al (1999) Expression analysis of new Ly49 genes: Most transcripts of Ly49j lack the transmembrane domain. Immunogenetics 49:685-691 (Pubitemid 29278456)
86. Mehta IK, Smith HR, Wang J et al (2001a) A "chimeric" C57l-derived Ly49 inhibitory receptor resembling the Ly49D activation receptor. Cell Immunol 209:29-41 (Pubitemid 32568564)
87. Mehta IK, Wang J, Roland J et al (2001b) Ly49A allelic variation and MHC class I specificity. Immunogenetics 53:572-583 (Pubitemid 33044437)
88. Merck E, Voyle RB, MacDonald HR (2009) Ly49D engagement on T lymphocytes induces TCRindependent activation and CD8 effector functions that control tumor growth. J Immunol 182:183-192
89. Michaelsson J, Achour A, Salcedo M et al (2000) Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur J Immunol 30:300-307 (Pubitemid 30011792)
90. Mishra AK, Zhang A, Niu T et al (2002) Substrate specificity of protein tyrosine phosphatase: Differential behavior of SHP-1 and SHP-2 towards signal regulation protein SIRPalpha1. J Cell Biochem 84:840-846 (Pubitemid 34113122)
91. Nakamura MC, Niemi EC, Fisher MJ et al (1997) Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J Exp Med 185:673-684 (Pubitemid 27098152)
92. Natarajan K, Boyd LF, Schuck P et al (1999) Interaction of the NK cell inhibitory receptor Ly49A with H-2Dd: Identification of a site distinct from the TCR site. Immunity 11:591-601
93. Olcese L, Lang P, Vely F et al (1996) Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol 156:4531-4534 (Pubitemid 26174429)
94. Olsson-Alheim MY, Sundback J, Karre K et al (1999) The MHC class I molecule H-2Dp inhibits murine NK cells via the inhibitory receptor Ly49A. J Immunol 162:7010-7014 (Pubitemid 29277667)
95. Orr MT, Sun JC, Hesslein DG et al (2009) Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection. J Exp Med 206:807-817
96. Orr MT, Murphy WJ, Lanier LL (2010) 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol 11:321-327
97. Palmieri G, Tullio V, Zingoni A et al (1999) CD94/NKG2-A inhibitory complex blocks CD16- triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells. J Immunol 162:7181-7188 (Pubitemid 29277689)
98. Peterson ME, Long EO (2008) Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity 29:578-588
99. Proteau MF, Rousselle E, Makrigiannis AP (2004) Mapping of the BALB/c Ly49 cluster defines a minimal natural killer cell receptor gene repertoire. Genomics 84:669-677 (Pubitemid 39310944)
100. Raulet DH, Held W, Correa I et al (1997) Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 155:41-52 (Pubitemid 27076057)
101. Robbins SH, Tessmer MS, Mikayama T et al (2004) Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection. J Immunol 173:259-266 (Pubitemid 38797350)
102. Romagne F, Andre P, Spee P et al (2009) Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells. Blood 114:2667-2677
103. Rouhi A, Lai CB, Cheng TP et al (2009) Evidence for high bi-allelic expression of activating Ly49 receptors. Nucleic Acids Res 37:5331-5342
104. Ruggeri L, Capanni M, Urbani E et al (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295:2097-2100 (Pubitemid 34229476)
105. Sasawatari S, Yoshizaki M, Taya C et al (2010) The Ly49Q receptor plays a crucial role in neutrophil polarization and migration by regulating raft trafficking. Immunity 32:200-213
106. Scarpellino L, Oeschger F, Guillaume P et al (2007) Interactions of Ly49 family receptors with MHC class I ligands in trans and cis. J Immunol 178:1277-1284 (Pubitemid 46154597)
107. Shlomchik WD, Couzens MS, Tang CB et al (1999) Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285:412-415 (Pubitemid 29343964)
108. Silver ET, Lavender KJ, Gong DE et al (2002) Allelic variation in the ectodomain of the inhibitory Ly-49G2 receptor alters its specificity for allogeneic and xenogeneic ligands. J Immunol 169:4752-4760 (Pubitemid 35217137)
109. Smith HR, Karlhofer FM, Yokoyama WM (1994) Ly-49 multigene family expressed by IL-2- activated NK cells. J Immunol 153:1068-1079 (Pubitemid 24228498)
110. Smith KM, Wu J, Bakker AB et al (1998) Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J Immunol 161:7-10 (Pubitemid 28285499)
111. Smith HR, Heusel JW, Mehta IK et al (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 99:8826-8831 (Pubitemid 34693643)
112. Stebbins CC, Watzl C, Billadeau DD et al (2003) Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol 23:6291-6299 (Pubitemid 37013105)
113. Sun JC, Lanier LL (2008) Cutting edge: Viral infection breaks NK cell tolerance to "missing self ". J Immunol 181:7453-7457
114. Sun JC, Beilke JN, Lanier LL (2009) Adaptive immune features of natural killer cells. Nature 457:557-561
115. Tai LH, Goulet ML, Belanger S et al (2007) Recognition of H-2 K(b) by Ly49Q suggests a role for class Ia MHC regulation of plasmacytoid dendritic cell function. Mol Immunol 44:2638-2646 (Pubitemid 46240325)
116. Tai LH, Goulet ML, Belanger S et al (2008) Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC. J Exp Med 205:3187-3199
117. Takei F, Brennan J, Mager DL (1997) The Ly-49 family: Genes, proteins and recognition of class I MHC. Immunol Rev 155:67-77 (Pubitemid 27076059)
118. Tonks NK, Neel BG (1996) From form to function: Signaling by protein tyrosine phosphatases. Cell 87:365-368 (Pubitemid 26374311)
119. Tortorella D, Gewurz BE, Furman MH et al (2000) Viral subversion of the immune system. Annu Rev Immunol 18:861-926 (Pubitemid 30365400)
120. Toyama-Sorimachi N, Tsujimura Y, Maruya M et al (2004) Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architecture. Proc Natl Acad Sci U S A 101:1016-1021 (Pubitemid 38160576)
121. Vahlne G, Lindholm K, Meier A et al (2010) In vivo tumor cell rejection induced by NK cell inhibitory receptor blockade: Maintained tolerance to normal cells even in the presence of IL-2. Eur J Immunol 40:813-823
122. Valiante NM, Phillips JH, Lanier LL et al (1996) Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp 36/PLC-gamma signaling complex in human natural killer (NK) cells. J Exp Med 184:2243-2250 (Pubitemid 27023724)
123. Van Beneden K, Stevenaert F, De Creus A et al (2001) Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells. J Immunol 166:4302-4311 (Pubitemid 32233710)
124. Van Beneden K, De Creus A, Stevenaert F et al (2002) Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes. J Immunol 168:3295-3302 (Pubitemid 34250391)
125. Van Den Broeck T, Stevenaert F, Taveirne S et al (2008) Ly49E-dependent inhibition of natural killer cells by urokinase plasminogen activator. Blood 112:5046-5051
126. Vivier E, Anfossi N (2004) Inhibitory NK-cell receptors on T cells: Witness of the past, actors of the future. Nat Rev Immunol 4:190-198 (Pubitemid 38339085)
127. Vyas YM, Mehta KM, Morgan M et al (2001) Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions. J Immunol 167:4358-4367 (Pubitemid 32954312)
128. Vyas YM, Maniar H, Dupont B (2002) Cutting edge: Differential segregation of the SRC homology 2-containing protein tyrosine phosphatase-1 within the early NK cell immune synapse distinguishes noncytolytic from cytolytic interactions. J Immunol 168:3150-3154 (Pubitemid 34250373)
129. Vyas YM, Maniar H, Lyddane CE et al (2004) Ligand binding to inhibitory killer cell Ig-like receptors induce colocalization with Src homology domain 2-containing protein tyrosine phosphatase 1 and interruption of ongoing activation signals. J Immunol 173:1571-1578 (Pubitemid 38971586)
130. Wang JW, Howson JM, Ghansah T et al (2002) Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Science 295:2094-2097 (Pubitemid 34229475)
131. Wilhelm BT, Gagnier L, Mager DL (2002) Sequence analysis of the ly49 cluster in C57BL/6 mice: A rapidly evolving multigene family in the immune system. Genomics 80:646-661 (Pubitemid 36062652)
132. Wong S, Freeman JD, Kelleher C et al (1991) Ly-49 multigene family. New members of a superfamily of type II membrane proteins with lectin-like domains. J Immunol 147:1417-1423
133. Wu MF, Raulet DH (1997) Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. J Immunol 158:1628-1633 (Pubitemid 127469516)
134. Yang J, Liang X, Niu T et al (1998) Crystal structure of the catalytic domain of protein-tyrosine phosphatase SHP-1. J Biol Chem 273:28199-28207 (Pubitemid 28496118)
135. Yokoyama WM, Kim S (2006) Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev 214:143-154 (Pubitemid 44707908)
136. Yokoyama WM, Plougastel BF (2003) Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 3:304-316 (Pubitemid 37328683)
137. Yu YY, George T, Dorfman JR et al (1996) The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity 4:67-76 (Pubitemid 26054937)
138. Yu MC, Su LL, Zou L et al (2008) An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells. Nat Immunol 9:898-907